When was VahatiCor founded?

VahatiCor was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is VahatiCor located?

VahatiCor is headquartered in Santa Clara, United States.

How many employees does VahatiCor have?

As of Sep 30, 2026, the latest employee count at VahatiCor is 20.

Is VahatiCor a funded company?

VahatiCor is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Nov 07, 2025.

When was the latest funding round of VahatiCor?

VahatiCor's latest funding was a $***** Series B round on Nov 07, 2025, with participation from 2 investors.

Where does VahatiCor rank among its competitors?

VahatiCor ranks 7th amongst 63 active competitors, of which 20 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was HeartIO, which secured $4.25M in Mar, 2026.

Who are the top competitors of VahatiCor?

VahatiCor's top competitors include HeartFocus, Anumana and CorVista. Among them, HeartIO secured the most recent funding round in March, 2026.

VahatiCor - 2026 Company Profile, Team, Funding & Competitors

VahatiCor is a series B company based in Santa Clara (United States), founded in 2021 by Marwan Berrada Sounni. It operates as a Platform offering solutions on addressing coronary microvascular disease. VahatiCor has raised $23M in funding from S3 Ventures. The company has 63 active competitors, including 20 funded and 2 that have exited. Its top competitors include companies like HeartFocus, Anumana and CorVista.

Company Details

Platform offering solutions on addressing coronary microvascular disease. It provides invasive device designed to restore natural blood flow and alleviate symptoms of chest pain, heaviness, and tightness. The flagship product, the A FLUX Reducer System, is a self expanding device that reduces pressure in the coronary sinus to enhance microvascular perfusion. The solution aims to enhance the quality of life for patients with refractory angina who have exhausted current medical therapies.

Website: vahaticor.com
Email ID: *****@vahaticor.com
Phone Number: +1 **********

Key Metrics

Founded Year

2021

Location

Santa Clara, United States

Stage

Series B

Total Funding

$23M in 1 round

Latest Funding Round

Series B, Nov 07, 2025, $*****

Investors

S3 Ventures & 1 more

Ranked

7^th among 63 active competitors

Employee Count

20 as on Sep 30, 2026

Similar Companies

HeartFocus & 66 more

View VahatiCor's full profile

VahatiCor has raised a total funding of $23M over 1 round. Its latest funding round was a Series B round on Nov 07, 2025 for $*****. 2 investors participated in its latest round. VahatiCor has 2 institutional investors.

Here is the list of recent funding rounds of VahatiCor:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 07, 2025	8076097	Series B	3781511	1251590	2739489	6886653

Access funding benchmarks and valuations. Sign up today!

View details of VahatiCor's funding rounds and investors

The founders of VahatiCor is Marwan Berrada Sounni.

Here are the details of VahatiCor's key team members:

Marwan Berrada Sounni: Co-Founder of VahatiCor and founder of 1 other company.
Contact Info: 1 email address

View details of VahatiCor's Founder profiles and Board Members

VahatiCor's employee count trend

VahatiCor has 20 employees as of Sep 26. Here is VahatiCor's employee count trend over the years:

Uncover VahatiCor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VahatiCor include HeartFocus, Anumana and CorVista. Here is the list of Top 10 competitors of VahatiCor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HeartFocus 2023, Bordeaux (France), Seed	AI-driven app for healthcare professionals to perform cardiac ultrasound exams	$6M	Racine², BNP Paribas Developpement & 4 others	62/100
2nd	Anumana 2021, Cambridge (United States), Series C	AI-based ECG detection and cardiology diagnosis solutions	$95.4M	Matrix Management Corp., Endowment Arm & 4 others	62/100
3rd	CorVista 2012, Toronto (Canada), Series C	Developer of diagnostic systems for identifying cardiovascular and pulmonary conditions	$89.8M	G Ventures, MedVenture Partners & 2 others	60/100
4th	Powerful Medical 2019, Bratislava (Slovakia), Series A	Developer of AI-powered platform for interpreting electrocardiograms and detecting heart conditions	$11.4M	Venture to Future Fund, Europa & 7 others	59/100
5th	Laza Medical 2022, Los Gatos (United States), Series A	AI-powered robotically-assisted imaging solutions for cardiovascular interventions	$36M	The Capital Partnership, Shifamed & 5 others	57/100
6th	Volta Medical 2016, Marseille (France), Series B	AI-based software developer for providing cardiac mapping assistance tools	$74.2M	Gilde Healthcare, Vensana Capital & 2 others	56/100
7th	VahatiCor 2021, Santa Clara (United States), Series B	Platform offering solutions on addressing coronary microvascular disease	$23M	S3 Ventures & 1 others	54/100
8th	Cardio Intelligence 2019, Minato City (Japan), Series B	AI-based medical devices for diagnosis and treatment of heart diseases	$3.22M	Shizuoka Bank, SMBC Venture Capital & 6 others	47/100
9th	HeartIO 2019, Pittsburgh (United States), Seed	Provider of AI-based platform for the diagnosis of heart abnormalities	$4.45M	Bessel, VU Venture Partners & 3 others	46/100
10th	Analytics4Life 2012, Toronto (Canada), Series C	Developer of diagnostic platform using AI for cardiovascular disease assessments	$69.2M	G Ventures, JLABS & 1 others	46/100